Sackler Family Member Admits Opioid Addiction Amid $6.5B Settlement Negotiations

The opioid crisis has taken a startling turn as the Sackler family, central figures in Purdue Pharma’s role in the epidemic, faces legal and personal repercussions. While the Sacklers negotiated a $6.5 billion settlement for their alleged role in producing addictive opioids, Joss Sackler—wife of former Purdue board member David Sackler—publicly admitted her own addiction to prescription opioids.

According to Bloomberg, Sackler pleaded guilty to obstructing a federal grand jury investigation after being caught in an illegal shipment of prescription drugs in 2024. Prosecutors revealed that Sackler deleted multiple WhatsApp messages implicating her as the recipient, leading to a single felony charge.

In a court statement on Wednesday, Sackler expressed remorse, saying:

“I am so truly sorry that when I was suffering from my addiction I made these poor choices and I am grateful for the medical care I have been able to get in my recovery.”

Sackler now faces a maximum of 20 years in prison, though Bloomberg notes her sentence will likely be far shorter. Her lawyer, Walter Norkin, emphasized that her case is “entirely unrelated to Purdue Pharma or any other members of her family,” attempting to distance her legal troubles from the broader opioid crisis.

The Sacklers and the Opioid Crisis: A Deeper Look

While the Sackler family has become a symbol of the opioid epidemic—responsible for over 800,000 deaths in the U.S. alone—the crisis extends far beyond one family. Research from Princeton University economists Anne Case and Angus Deaton (2022) highlights that the surge in drug deaths was driven by decades of economic decline among working-class Americans with limited education. Corporations exploited this vulnerability.

During the 1990s and early 2000s, major pharmacy chains—CVS, Walgreens, and Walmart—aggressively marketed opioids as safe and non-addictive. They lobbied government officials and collaborated with doctors overprescribing opioids to boost profits. In 2021, a Cleveland jury ruled that these companies contributed to the crisis by failing to monitor opioid prescriptions, a lapse that coincided with massive financial gains.

Where Does the Sackler Family Stand Now?

The Sackler family has largely evaded accountability. Despite Purdue Pharma’s recent $7.4 billion settlement and its closure last week, some Sacklers remain at the helm of Mundipharma, an international drug consortium. This raises concerns about how much of their fortune—allegedly gained through the opioid trade—remains unaccounted for overseas.

While opioid addiction is a devastating reality, the irony of Joss Sackler’s admission amid her family’s legal battles underscores the crisis’s far-reaching consequences. The case serves as a stark reminder that the opioid epidemic’s roots extend beyond any single entity—and that justice, when it comes, may take unexpected forms.